Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ansari

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
Journal of Pediatric Hematology/Oncology|January 23, 2013
Is acute fibrinous and organizing pneumonia the expression of immune dysregulation?Sonia Labarinas, Fabienne Gumy-Pause, Anne-Laure Rougemont, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletionYan Beauverd, Eddy Roosnek, Yordanka Tirefort, et al.
Pediatric Transplantation|April 17, 2025
Meeting the Challenges of Post-Transplant Lymphoproliferative Disorders After Liver Transplantation in Children: A Proposed Diagnostic and Management AlgorithmNathalie Marie Rock, Antonin Bouroumeau, Danai Papangelopoulou, et al.
BMC Infectious Diseases|March 8, 2018
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective studyOlga Chatzis, Stephanie Darbre, Jérôme Pasquier, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantationTiago Nava, Nastya Kassir, Mohamed Aziz Rezgui, et al.
Frontiers in Pediatrics|September 23, 2022
Testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys: A 6 year experience from a Swiss multi-center networkDehlia Moussaoui, Anna Surbone, Cécile Adam, et al.
Bone Marrow Transplantation|September 13, 2024
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, et al.
JMIR Research Protocols|March 17, 2026
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort StudySwetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
Journal of Pediatric Hematology/Oncology|January 23, 2013
Is acute fibrinous and organizing pneumonia the expression of immune dysregulation?Sonia Labarinas, Fabienne Gumy-Pause, Anne-Laure Rougemont, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletionYan Beauverd, Eddy Roosnek, Yordanka Tirefort, et al.
Pediatric Transplantation|April 17, 2025
Meeting the Challenges of Post-Transplant Lymphoproliferative Disorders After Liver Transplantation in Children: A Proposed Diagnostic and Management AlgorithmNathalie Marie Rock, Antonin Bouroumeau, Danai Papangelopoulou, et al.
BMC Infectious Diseases|March 8, 2018
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective studyOlga Chatzis, Stephanie Darbre, Jérôme Pasquier, et al.
British Journal of Clinical Pharmacology|February 23, 2018
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantationTiago Nava, Nastya Kassir, Mohamed Aziz Rezgui, et al.
Frontiers in Pediatrics|September 23, 2022
Testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys: A 6 year experience from a Swiss multi-center networkDehlia Moussaoui, Anna Surbone, Cécile Adam, et al.
Bone Marrow Transplantation|September 13, 2024
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, et al.
JMIR Research Protocols|March 17, 2026
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort StudySwetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss, et al.
Pageof 20